other:Article Title: COPI vesicle formation and N -myristoylation are targetable vulnerabilities of senescent cells
Article Snippet: The following primary antibodies were used in this study: mouse monoclonal anti-BrdU (3D4, BD Biosciences, 555627) 1:2,000, mouse monoclonal anti-p16 INK4a (JC8, CRUK) 1:1,000, rabbit polyclonal anti-glyceraldehyde 3-phosphate dehydrogenase (anti-GAPDH) (Abcam, ab22555) 1:2,000, mouse monoclonal anti-IL-8 (6217, R&D systems, MAB208) 1:100, goat polyclonal anti-IL-6 (R&D Systems, AF-206-NA) 1:40–1:200, mouse monoclonal anti-ARF1/3/5/6 (1D9, Invitrogen, MA3-060) 1:500, rabbit monoclonal anti-COPB2 (899, gifted from F. Weiland) 1:10,000, mouse monoclonal anti-EEA1 (14, BD Biosciences, 610457) 1:200, rabbit polyclonal anti-XBP1 (Abcam, ab37152) 1:200, rabbit polyclonal anti-ATF6 (Abcam, ab37149) 1:500, sheep polyclonal anti-TGN46 (Bio-Rad, AHP500G) 1:400, mouse monoclonal anti-GM130 (35, BD Biosciences, 610822) 1:500, mouse monoclonal anti-CHOP (L63F7, CST, 2895S) 1:1,000, rabbit monoclonal anti-p21 CIP1 (12D1, CST, 2947S) 1:2,000, rabbit monoclonal anti-p21 CIP1 (EPR18021, Abcam, ab188224) 1:700, mouse monoclonal anti-N-Ras (F155, Santa Cruz, sc-31) 1:100, mouse monoclonal anti-β-catenin (6F9, Sigma, C7082) 1:500, rabbit polyclonal anti-β-catenin (Thermo, RB-9035-P1) 1:500, mouse monoclonal anti-synaptophysin (27G12, Leica, SYNAP-299-L) 1:200, rabbit polyclonal anti-CC3 (CST, 9661S) 1:1,000, goat polyclonal anti-CXCL1 (R&D, AF-275) 1:100, mouse monoclonal anti-BMP2/4 (100230, R&D, MAB3552), mouse monoclonal anti-VEGF (23410, R&D MAB2931) 1:100, mouse monoclonal anti-GM-CSF (3209, R&D, MAB215) 1:100, rabbit polyclonal anti-CD68 (Abcam, ab125212) 1:100, rabbit polyclonal anti-ARF1 (10790-1-AP, Proteintech) 1:1,000, rabbit polyclonal anti-ARL1 (16012-1-AP, Proteintech) 1:1,000, rabbit polyclonal anti-PPM1B (HPA-016745, Cambridge Bioscience) 1:1,000 and rabbit polyclonal, mouse monoclonal anti-TUBA (ab1729, Abcam) 1:1,000.
Article Title: COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells.
Article Snippet: The following primary antibodies were used in this study: mouse monoclonal anti-BrdU (3D4, BD Biosciences, 555627) 1:2,000, mouse monoclonal anti-p16INK4a ( JC8, CRUK) 1:1,000, rabbit polyclonal anti-glyceraldehyde 3-phosphate dehydrogenase (anti-GAPDH) (Abcam, ab22555) 1:2,000, mouse monoclonal anti-IL-8 (6217, R&D systems, MAB208) 1:100, goat polyclonal anti-IL-6 (R&D Systems, AF-206-NA) 1:40–1:200, mouse monoclonal anti-ARF1/3/5/6 (1D9, Invitrogen, MA3-060) 1:500, rabbit monoclonal anti-COPB2 (899, gifted from F. Weiland) 1:10,000, mouse monoclonal anti-EEA1 (14, BD Biosciences, 610457) 1:200, rabbit polyclonal anti-XBP1 (Abcam, ab37152) 1:200, rabbit polyclonal anti-ATF6 (Abcam, ab37149) 1:500, sheep polyclonal anti-TGN46 (Bio-Rad, AHP500G) 1:400, mouse monoclonal anti-GM130 (35, BD Biosciences, 610822) 1:500, mouse monoclonal anti-CHOP (L63F7, CST, 2895S) 1:1,000, rabbit monoclonal anti-p21CIP1 (12D1, CST, 2947S) 1:2,000, rabbit monoclonal anti-p21CIP1 (EPR18021, Abcam, ab188224) 1:700, mouse monoclonal anti-N-Ras (F155, Santa Cruz, sc-31) 1:100, mouse monoclonal anti-β-catenin (6F9, Sigma, C7082) 1:500, rabbit polyclonal anti-β-catenin (Thermo, RB-9035-P1) 1:500, mouse monoclonal anti-synaptophysin (27G12, Leica, SYNAP-299-L) 1:200, rabbit polyclonal anti-CC3 (CST, 9661S) 1:1,000, goat polyclonal anti-CXCL1 (R&D, AF-275) 1:100, mouse monoclonal anti-BMP2/4 (100230, R&D, MAB3552), mouse monoclonal anti-VEGF (23410, R&D MAB2931) 1:100, mouse monoclonal anti-GM-CSF (3209, R&D, MAB215) 1:100, rabbit polyclonal anti-CD68 (Abcam, ab125212) 1:100, rabbit polyclonal anti-ARF1 (10790-1-AP, Proteintech) 1:1,000, rabbit polyclonal anti-ARL1 (16012-1-AP, Proteintech) 1:1,000, rabbit polyclonal anti-PPM1B (HPA-016745, Cambridge Bioscience) 1:1,000 and rabbit polyclonal, mouse monoclonal anti-TUBA (ab1729, Abcam) 1:1,000.
|